Couette B, Lombes M, Baulieu E E, Rafestin-Oblin M E
Lab. Hormones, INSERM U 33, Bicêtre, France.
Biochem J. 1992 Mar 15;282 ( Pt 3)(Pt 3):697-702. doi: 10.1042/bj2820697.
To elucidate the mechanism of action of aldosterone antagonists, we studied the interaction of spironolactone with the chick mineralocorticosteroid receptor (MR). Intestinal cytosol contains specific spironolactone-binding sites (Kd approximately 3 nM; max. no. of binding sites approximately 100 fmol/mg of protein) that have been identified as MRs by competition experiments with steroid ligands and with the monoclonal anti-idiotypic antibody H10E that interacts with aldosterone-binding domain of the MR. Binding studies indicate that aldosterone and spironolactone bind to the MR through a common site that encompasses the epitope recognized by H10E. At 4 degrees C, spironolactone dissociates much more rapidly from the cytosol 8-9 S form of MR (t1/2 38 min) than does aldosterone (t1/2 3240 min). A high dissociation rate was also observed for progesterone, a natural aldosterone antagonist (t1/2 84 min). The covalent linkage of the 90 kDa heat shock protein (hsp90) to the ligand-binding subunit of MR with dimethyl pimelimidate did not notably modify the rate of dissociation of spironolactone from the receptor (t1/2 96 min), excluding the possibility that the rapid dissociation rate of the antagonist was related to hsp90 release. The effects of aldosterone and the two anti-mineralocorticosteroids on the 8-9 S heterooligomeric structure of the MR differed strikingly. Using low-salt density-gradient centrifugation analysis, aldosterone-labelled receptors were recovered as 8-9S complexes, whereas 4 S entities were detected after spironolactone and progesterone binding. This indicated that, under the experimental conditions used, aldosterone antagonists facilitate hsp90 release and thus do not stabilize the non-DNA-binding 8-9S form of MR. We propose that the combination of rapid dissociation of the ligand and a weakened hsp90-receptor interaction is involved in the anti-mineralococorticosteroid activity of aldosterone antagonists.
为阐明醛固酮拮抗剂的作用机制,我们研究了螺内酯与鸡盐皮质激素受体(MR)的相互作用。肠细胞溶质含有特异性螺内酯结合位点(解离常数约为3 nM;最大结合位点数约为100 fmol/mg蛋白质),通过与类固醇配体以及与与MR醛固酮结合域相互作用的单克隆抗独特型抗体H10E进行竞争实验,这些位点已被鉴定为MR。结合研究表明,醛固酮和螺内酯通过一个共同位点与MR结合,该位点包含H10E识别的表位。在4℃时,螺内酯从MR的细胞溶质8 - 9S形式上解离的速度(半衰期38分钟)比醛固酮(半衰期3240分钟)快得多。对于天然醛固酮拮抗剂孕酮,也观察到了较高的解离速率(半衰期84分钟)。用庚二酸二甲酯使90 kDa热休克蛋白(hsp90)与MR的配体结合亚基共价连接,并未显著改变螺内酯从受体上解离的速率(半衰期96分钟),排除了拮抗剂快速解离速率与hsp90释放有关的可能性。醛固酮和两种抗盐皮质激素对MR的8 - 9S异源寡聚体结构的影响显著不同。使用低盐密度梯度离心分析,醛固酮标记的受体以8 - 9S复合物形式回收,而螺内酯和孕酮结合后检测到4S实体。这表明,在所使用的实验条件下,醛固酮拮抗剂促进hsp90释放,因此不能稳定MR的非DNA结合8 - 9S形式。我们提出,配体的快速解离和hsp90 - 受体相互作用减弱的共同作用参与了醛固酮拮抗剂的抗盐皮质激素活性。